Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Apraglutide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ironwood makes bid for $1B GI drug with subgroup data
    Ironwood makes bid for $1B GI drug with subgroup data

    29 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ramping-fda-submission-ironwood-makes-further-bid-1b-gi-drug-subgroup-data

    FIERCE BIOTECH
    29 Oct 2024
    Share Share
    Ironwood Presents Apraglutide SBS-IF Data At DDW Late-Breaker
    Ironwood Presents Apraglutide SBS-IF Data At DDW Late-Breaker

    21 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240521515089/en

    BUSINESSWIRE
    21 May 2024
    Share Share
    Ironwood: Apraglutide SBS-IF Data At DDW 2024
    Ironwood: Apraglutide SBS-IF Data At DDW 2024

    01 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240501757166/en

    BUSINESSWIRE
    01 May 2024
    Share Share
    Ironwood spies new frontier for $1B drug in exploratory trial
    Ironwood spies new frontier for $1B drug in exploratory trial

    29 Mar 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ironwood-spies-new-frontier-1b-drug-exploratory-rare-disease-trial

    FIERCE BIOTECH
    29 Mar 2024
    Share Share
    Ironwood Results from Ph II Trial of Apraglutide in Patients with SR GI aGVHD
    Ironwood Results from Ph II Trial of Apraglutide in Patients with SR GI aGVHD

    28 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240328865627/en

    BUSINESSWIRE
    28 Mar 2024
    Share Share
    Ironwood's bowel disease drug meets main goal of late-stage study
    Ironwood's bowel disease drug meets main goal of late-stage study

    01 Mar 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/ironwood-says-bowel-disease-treatment-meets-main-goal-late-stage-trial-2024-02-29/

    REUTERS
    01 Mar 2024
    Share Share